CompletedNCT01623245

Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy

Studying Wild type ATTR amyloidosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Thibaud Damy
Principal Investigator
Thibaud DAMY
Assistance Publique - Hôpitaux de Paris
Enrollment
294 enrolled
Eligibility
18 years · All sexes
Timeline
20122014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01623245 on ClinicalTrials.gov

Other trials for Wild type ATTR amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Wild type ATTR amyloidosis

← Back to all trials